Metcela Fetches $12.7M Series B

Jan 04, 2022•over 3 years ago

Amount Raised

$12.7 Million

Round Type

series b

Description

Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.

Company Information

Company

Metcela

About

Metcela Inc. is a pioneer biotechnology company founded in Japan. Metcela aims to be the first to commercialize biological products that heal damaged heart muscle to treat heart failure.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Metcela Fetches $12.7M Series B

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information